Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OptiGene is a UK-based biotechnology company specializing in the development and manufacture of innovative solutions for rapid isothermal nucleic acid amplification. The company is best known for its proprietary LAMP (Loop-mediated Isothermal Amplification) technology and its range of Genie instruments, which enable sensitive and specific detection of DNA and RNA in field and point-of-care settings. OptiGene provides a comprehensive suite of products, including high-performance master mixes, enzymes, and portable diagnostic platforms used across human healthcare, plant pathology, food safety, and veterinary medicine. During the COVID-19 pandemic, the company's Direct LAMP assay gained significant prominence for its ability to provide rapid results without the need for complex RNA extraction. Their technology is characterized by high speed, simplicity, and the ability to operate outside of traditional laboratory environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OptiGene.